The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 13, 2018

Filed:

Dec. 21, 2017
Applicant:

Novo Nordisk A/s, Bagsvaerd, DK;

Inventors:

Birgit Wieczorek, Koebenhavn N, DK;

Tina Moeller Tagmose, Ballerup, DK;

Kristian Sass-Oerum, Koebenhavn, DK;

Birgitte Andersen, Maaloev, DK;

Joergen Olsen, Vaerloese, DK;

Assignee:

Novo Nordisk A/S, Bagsvaerd, DK;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/18 (2006.01); C07K 14/50 (2006.01); A61K 47/54 (2017.01);
U.S. Cl.
CPC ...
A61K 38/1825 (2013.01); A61K 47/542 (2017.08); C07K 14/50 (2013.01); A61K 38/00 (2013.01);
Abstract

The invention relates to a derivative of a FGF21 protein having a cysteine residue at a position corresponding to position 167, 169, 170, 171, 172, 173, 174, 175 and in particular position 180 or position 181 of mature human FGF21 and derivatives thereof having a side chain attached to this cysteine. The FGF21 derivatives of the invention display high potency towards the FGF receptors. The invention also relates to pharmaceutical compositions comprising such FGF21 derivatives and pharmaceutically acceptable excipients, as well as the medical use of the FGF21 derivatives.


Find Patent Forward Citations

Loading…